These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 20381801)

  • 21. The Orientation of Gastric Biopsy Samples Improves the Inter-observer Agreement of the OLGA Staging System.
    Cotruta B; Gheorghe C; Iacob R; Dumbrava M; Radu C; Bancila I; Becheanu G
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):351-356. PubMed ID: 29253048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study.
    Rugge M; de Boni M; Pennelli G; de Bona M; Giacomelli L; Fassan M; Basso D; Plebani M; Graham DY
    Aliment Pharmacol Ther; 2010 May; 31(10):1104-11. PubMed ID: 20180784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages.
    Kim YI; Kook MC; Cho SJ; Lee JY; Kim CG; Joo J; Choi IJ
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28940945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
    Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
    Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single vial is enough in the absence of endoscopic suspected intestinal metaplasia - less is more!
    Castro R; Esposito G; Libânio D; Afonso L; Annibale B; Dinis-Ribeiro M; Pimentel-Nunes P
    Scand J Gastroenterol; 2019 May; 54(5):673-677. PubMed ID: 31084230
    [No Abstract]   [Full Text] [Related]  

  • 26. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
    Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
    Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.
    Salazar BE; Pérez-Cala T; Gomez-Villegas SI; Cardona-Zapata L; Pazos-Bastidas S; Cardona-Estepa A; Vélez-Gómez DE; Justinico-Castro JA; Bernal-Cobo A; Dávila-Giraldo HA; Benítez-Guerra JC; Valencia-Cárdenas JT; Ospina EJ; Castaño-Llano R; Bravo MM; Cataño-Correa JC; Zabaleta J; Trespalacios-Rangel AA; Cock-Botero AM; Roldán-Pérez MI; Martínez A
    Virchows Arch; 2022 Apr; 480(4):759-769. PubMed ID: 35089403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
    Ogutmen Koc D; Bektas S
    Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems.
    Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
    Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
    Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic atrophic gastritis: endoscopic and histological concordances, associated injuries and application of virtual chromoendoscopy].
    Liu Bejarano H
    Rev Gastroenterol Peru; 2011; 31(2):116-23. PubMed ID: 21836651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of atrophic gastritis using the OLGA system.
    Satoh K; Osawa H; Yoshizawa M; Nakano H; Hirasawa T; Kihira K; Sugano K
    Helicobacter; 2008 Jun; 13(3):225-9. PubMed ID: 18466398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy.
    Fassan M; Pizzi M; Farinati F; Nitti D; Zagonel V; Genta RM; Rugge M
    Am J Clin Pathol; 2012 May; 137(5):727-32. PubMed ID: 22523210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.
    Yue H; Shan L; Bin L
    Gastric Cancer; 2018 Jul; 21(4):579-587. PubMed ID: 29460004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ROLE OF INCISURA ANGULARIS BIOPSY IN GASTRITIS STAGING AND RISK ASSESSMENT OF GASTRIC CÂNCER.
    Ferrari F; Ogata DC; Mello CAL
    Arq Gastroenterol; 2023; 60(4):478-489. PubMed ID: 38018553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.
    Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastritis staging in clinical practice: the OLGA staging system.
    Rugge M; Meggio A; Pennelli G; Piscioli F; Giacomelli L; De Pretis G; Graham DY
    Gut; 2007 May; 56(5):631-6. PubMed ID: 17142647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
    Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
    Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.